Novo Drug Patent Portfolio
Novo owns 11 orange book drugs protected by 80 US patents with Fiasp having the least patent protection, holding only 1 patent. And Saxenda with maximum patent protection, holding 48 patents. Given below is the complete list of Novo's drugs and the patents protecting them.
1. Fiasp
Fiasp is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8324157 | Preparation comprising insulin, nicotinamide and an amino acid |
25 Jun, 2030
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fiasp's drug page
2. Fiasp Flextouch
Fiasp Flextouch is protected by 20 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US8324157 | Preparation comprising insulin, nicotinamide and an amino acid |
25 Jun, 2030
(5 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(3 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 2 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Fiasp Flextouch's drug page
3. Macrilen
Macrilen is protected by 2 patents, out of which 1 has expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8192719 | Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds |
12 Oct, 2027
(3 years from now)
| Active |
| US6861409 | Growth hormone secretagogues |
01 Aug, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Macrilen's drug page
4. Ozempic
Ozempic is protected by 26 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10335462 | Use of long-acting GLP-1 peptides |
21 Jun, 2033
(8 years from now)
| Active |
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US8129343 | Acylated GLP-1 compounds |
05 Dec, 2031
(7 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
29 Sep, 2027
(3 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(3 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US11097063 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8536122 | Acylated GLP-1 compounds |
20 Mar, 2026
(1 year, 5 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US11311679 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US11446443 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US8114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
13 Aug, 2025
(10 months from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(3 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 2 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ozempic's drug page
5. Rivfloza
Rivfloza is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11286488 | Methods and compositions for inhibiting expression of LDHA |
12 Oct, 2038
(14 years from now)
| Active |
| US11661604 | Methods and compositions for inhibiting expression of LDHA |
12 Oct, 2038
(14 years from now)
| Active |
| US11053502 | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
29 Oct, 2035
(11 years from now)
| Active |
| US10351854 | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
09 Oct, 2035
(11 years from now)
| Active |
| US10738311 | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
09 Oct, 2035
(11 years from now)
| Active |
| US11359203 | Therapeutic inhibition of lactate dehydrogenase and agents therefor |
09 Oct, 2035
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rivfloza's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List
6. Rybelsus
Rybelsus is protected by 11 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10278923 | Oral dosing of GLP-1 compounds |
02 May, 2034
(9 years from now)
| Active |
| US10933120 | Compositions of GLP-1 peptides and preparation thereof |
15 Mar, 2033
(8 years from now)
| Active |
| US11759501 | Compositions of GLP-1 peptides and preparation thereof |
15 Mar, 2033
(8 years from now)
| Active |
| US11759502 | Compositions of GLP-1 peptides and preparation thereof |
15 Mar, 2033
(8 years from now)
| Active |
| US11759503 | Compositions of GLP-1 peptides and preparation thereof |
15 Mar, 2033
(8 years from now)
| Active |
| US10086047 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid |
16 Dec, 2031
(7 years from now)
| Active |
| US10960052 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl) amino) caprylic acid |
16 Dec, 2031
(7 years from now)
| Active |
| US11382957 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid |
16 Dec, 2031
(7 years from now)
| Active |
| US9278123 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid |
16 Dec, 2031
(7 years from now)
| Active |
| US8129343 | Acylated GLP-1 compounds |
05 Dec, 2031
(7 years from now)
| Active |
| US8536122 | Acylated GLP-1 compounds |
20 Mar, 2026
(1 year, 5 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Rybelsus's drug page
7. Ryzodeg 70/30
Ryzodeg 70/30 is protected by 22 patents, out of which 6 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9884094 | Method of treating diabetes mellitus |
01 May, 2033
(8 years from now)
| Active |
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US7615532 | Insulin derivatives |
28 Jun, 2029
(4 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(3 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(3 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 2 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US5866538 | Insulin preparations containing NaCl |
20 Jun, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Ryzodeg 70/30's drug page
8. Saxenda
Saxenda is protected by 48 patents, out of which 15 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9968659
(Pediatric)
| Liraglutide in cardiovascular conditions |
09 Jul, 2037
(12 years from now)
| Active |
| US9968659 | Liraglutide in cardiovascular conditions |
09 Jan, 2037
(12 years from now)
| Active |
| US9132239
(Pediatric)
| Dial-down mechanism for wind-up pen |
01 Aug, 2032
(7 years from now)
| Active |
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US9457154
(Pediatric)
| Injection device with an end of dose feedback mechanism |
27 Mar, 2028
(3 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(3 years from now)
| Active |
| US9687611
(Pediatric)
| Injection device with torsion spring and rotatable display |
27 Aug, 2027
(2 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| USRE46363
(Pediatric)
| Dial-down mechanism for wind-up pen |
03 Feb, 2027
(2 years from now)
| Active |
| US10220155
(Pediatric)
| Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jan, 2027
(2 years from now)
| Active |
| US8920383
(Pediatric)
| Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jan, 2027
(2 years from now)
| Active |
| US9775953
(Pediatric)
| Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jan, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| US9108002
(Pediatric)
| Automatic injection device with a top release mechanism |
26 Jul, 2026
(1 year, 10 months from now)
| Active |
| US9616180
(Pediatric)
| Automatic injection device with a top release mechanism |
20 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9861757
(Pediatric)
| Injection device with an end of dose feedback mechanism |
20 Jul, 2026
(1 year, 9 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US11097063 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8684969
(Pediatric)
| Injection device with torsion spring and rotatable display |
20 Apr, 2026
(1 year, 6 months from now)
| Active |
| US8114833
(Pediatric)
| Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
13 Feb, 2026
(1 year, 4 months from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
26 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US11311679 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US11446443 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US8114833 | Propylene glycol-containing peptide formulations which are optimal for production and for use in injection devices |
13 Aug, 2025
(10 months from now)
| Active |
| US7762994
(Pediatric)
| Needle mounting system and a method for mounting a needle assembly |
23 Nov, 2024
(2 months from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(3 months ago)
| Expired |
| US8579869
(Pediatric)
| Needle mounting system and a method for mounting a needle assembly |
30 Dec, 2023
(8 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 2 months ago)
| Expired |
| US6268343
(Pediatric)
| Derivatives of GLP-1 analogs |
22 Feb, 2023
(1 year, 6 months ago)
| Expired |
| US8846618
(Pediatric)
| Stable formulation of modified GLP-1 |
27 Dec, 2022
(1 year, 8 months ago)
| Expired |
| US6268343 | Derivatives of GLP-1 analogs |
22 Aug, 2022
(2 years ago)
| Expired |
| US8672898
(Pediatric)
| Automatic injection device with reset feature |
02 Jul, 2022
(2 years ago)
| Expired |
| US9486588
(Pediatric)
| Automatic injection device with reset feature |
02 Jul, 2022
(2 years ago)
| Expired |
| US6899699
(Pediatric)
| Automatic injection device with reset feature |
01 Jul, 2022
(2 years ago)
| Expired |
| US8846618 | Stable formulation of modified GLP-1 |
27 Jun, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
01 Jan, 2022
(2 years ago)
| Expired |
| US6458924 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
| US7235627 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Saxenda's drug page
9. Tresiba
Tresiba is protected by 20 patents, out of which 5 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US7615532 | Insulin derivatives |
28 Jun, 2029
(4 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(3 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(3 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 2 months ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tresiba's drug page
10. Wegovy
Wegovy is protected by 7 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11318191 | GLP-1 compositions and uses thereof |
17 Feb, 2041
(16 years from now)
| Active |
| US12029779 | Semaglutide in medical therapy |
10 Oct, 2038
(14 years from now)
| Active |
| US10888605 | GLP-1 compositions and uses thereof |
24 Aug, 2038
(13 years from now)
| Active |
| US11752198 | GLP-1 compositions and uses thereof |
24 Aug, 2038
(13 years from now)
| Active |
| US9764003 | Use of long-acting GLP-1 peptides |
21 Jun, 2033
(8 years from now)
| Active |
| US8129343 | Acylated GLP-1 compounds |
05 Dec, 2031
(7 years from now)
| Active |
| US8536122 | Acylated GLP-1 compounds |
20 Mar, 2026
(1 year, 5 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Wegovy's drug page
11. Xultophy 100/3.6
Xultophy 100/3.6 is protected by 45 patents, out of which 15 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9132239
(Pediatric)
| Dial-down mechanism for wind-up pen |
01 Aug, 2032
(7 years from now)
| Active |
| US9132239 | Dial-down mechanism for wind-up pen |
01 Feb, 2032
(7 years from now)
| Active |
| US7615532
(Pediatric)
| Insulin derivatives |
28 Dec, 2029
(5 years from now)
| Active |
| US8937042
(Pediatric)
| Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide |
05 Nov, 2029
(5 years from now)
| Active |
| US7615532 | Insulin derivatives |
28 Jun, 2029
(4 years from now)
| Active |
| US8937042 | Pharmaceutical compositions comprising GLP-1 peptides or extendin-4 and a basal insulin peptide |
05 May, 2029
(4 years from now)
| Active |
| US9457154
(Pediatric)
| Injection device with an end of dose feedback mechanism |
27 Mar, 2028
(3 years from now)
| Active |
| US9457154 | Injection device with an end of dose feedback mechanism |
27 Sep, 2027
(3 years from now)
| Active |
| US9687611
(Pediatric)
| Injection device with torsion spring and rotatable display |
27 Aug, 2027
(2 years from now)
| Active |
| US9687611 | Injection device with torsion spring and rotatable display |
27 Feb, 2027
(2 years from now)
| Active |
| USRE46363
(Pediatric)
| Dial-down mechanism for wind-up pen |
03 Feb, 2027
(2 years from now)
| Active |
| US10220155
(Pediatric)
| Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jan, 2027
(2 years from now)
| Active |
| US8920383
(Pediatric)
| Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jan, 2027
(2 years from now)
| Active |
| US9775953
(Pediatric)
| Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jan, 2027
(2 years from now)
| Active |
| US7686786 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| USRE46363 | Dial-down mechanism for wind-up pen |
03 Aug, 2026
(1 year, 10 months from now)
| Active |
| US9108002
(Pediatric)
| Automatic injection device with a top release mechanism |
20 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9616180
(Pediatric)
| Automatic injection device with a top release mechanism |
20 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9861757
(Pediatric)
| Injection device with an end of dose feedback mechanism |
20 Jul, 2026
(1 year, 9 months from now)
| Active |
| US10220155 | Syringe device with a dose limiting mechanism and an additional safety mechanism |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8920383 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US9775953 | Dose mechanism for an injection device for limiting a dose setting corresponding to the amount of medicament left |
17 Jul, 2026
(1 year, 9 months from now)
| Active |
| US8684969
(Pediatric)
| Injection device with torsion spring and rotatable display |
20 Apr, 2026
(1 year, 6 months from now)
| Active |
| US10357616 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US10376652 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9108002 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9616180 | Automatic injection device with a top release mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US9861757 | Injection device with an end of dose feedback mechanism |
20 Jan, 2026
(1 year, 4 months from now)
| Active |
| US8684969 | Injection device with torsion spring and rotatable display |
20 Oct, 2025
(1 year, 30 days from now)
| Active |
| US7762994
(Pediatric)
| Needle mounting system and a method for mounting a needle assembly |
23 Nov, 2024
(2 months from now)
| Active |
| US7762994 | Needle mounting system and a method for mounting a needle assembly |
23 May, 2024
(3 months ago)
| Expired |
| US8579869
(Pediatric)
| Needle mounting system and a method for mounting a needle assembly |
30 Dec, 2023
(8 months ago)
| Expired |
| US8579869 | Needle mounting system and a method for mounting a needle assembly |
30 Jun, 2023
(1 year, 2 months ago)
| Expired |
| US6268343
(Pediatric)
| Derivatives of GLP-1 analogs |
22 Feb, 2023
(1 year, 6 months ago)
| Expired |
| US8846618
(Pediatric)
| Stable formulation of modified GLP-1 |
27 Dec, 2022
(1 year, 8 months ago)
| Expired |
| US6268343 | Derivatives of GLP-1 analogs |
22 Aug, 2022
(2 years ago)
| Expired |
| US6899699
(Pediatric)
| Automatic injection device with reset feature |
02 Jul, 2022
(2 years ago)
| Expired |
| US8672898
(Pediatric)
| Automatic injection device with reset feature |
02 Jul, 2022
(2 years ago)
| Expired |
| US9486588
(Pediatric)
| Automatic injection device with reset feature |
02 Jul, 2022
(2 years ago)
| Expired |
| US8846618 | Stable formulation of modified GLP-1 |
27 Jun, 2022
(2 years ago)
| Expired |
| US6899699 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US8672898 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US9486588 | Automatic injection device with reset feature |
02 Jan, 2022
(2 years ago)
| Expired |
| US6458924 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
| US7235627 | Derivatives of GLP-1 analogs |
22 Aug, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Xultophy 100/3.6's drug page